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Abstract We investigated whether activation of integrin 
receptors could modulate the expression of monocyte chemotac- 
tic protein-1 (MCP-1) in human hepatic stellate cells (HSC), 
mesenchymal cells responsible for extracellular matrix synthesis 
within the liver. When compared to non-adherent cells, HSC 
plated on collagen types I or IV, or fibronectin, showed increased 
MCP-I gene expression and protein secretion in the conditioned 
medium. Increased MCP-1 secretion was also observed when 
cells were plated on dishes coated with a monoclonal antibody 
directed against the [~l-integrin subunit, demonstrating that 
ligation of [~l-integrins is sufficient to stimulate MCP-I 
expression. Conversely, integrin-independent cell adhesion on 
poly-L-lysine did not modify MCP-1 secretion. Disruption of the 
actin cytoskeleton by cytochalasin D blocked the collagen- 
dependent increase in MCP-1 secretion. Chemotactic assay of
HSC-conditioned medium showed that HSC plated on collagen 
secrete higher amounts of chemotactic factors for lymphomono- 
cytes, and that MCP-1 accounts for the great majority of this 
effect. These findings indicate a novel mechanism of MCP-I 
regulation possibly relevant in those conditions where HSC 
interact with an altered extracellular matrix. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Infiltrating leukocytes are a salient feature of a variety of 
inflammatory conditions and often contribute to the patho- 
genesis of the underlying disease. Chemokines, or chemotactic 
cytokines, are a family of proteins which are potent chemo- 
tactic factors for different classes of leukocytes. Four sub- 
groups are known, referred to as CXC, CX3C, CC, or C 
chemokines, based on the position of conserved cysteine res- 
idues [1,2]. CC chemokines generally attract monocytes and 
lymphocytes but not neutrophils. Members of this group in- 
clude monocyte chemotactic protein (MCP)-I ,  which is a ma- 
jor chemotactic factor for monocytes and T-lymphocytes [3- 
6]. MCP- l  is secreted by transformed and non-transformed 
cells [7--10] and its actions on target cells are mediated by 
the CCR2 chemokine receptor [11,12]. Expression of MCP-I  
is up-regulated in different diseases, including atherosclerosis, 
pulmonary fibrosis, renal and liver diseases [13-16]. 
The liver response to injury is similar to the one observed in 
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other tissues, leading to a reparative response and, when the 
injury is prolonged, to tissue fibrosis and scarring [17]. Accu- 
mulating evidence indicates that the hepatic stellate cells 
(HSC) play a pivotal role in the reparative response to liver 
injury, through proliferation and secretion of extracellular 
matrix (ECM) [17,18]. More recently, it has been reported 
that HSC may coordinate the recruitment of leukocytes 
through secretion of chemokines, including MCP-I [19,20]. 
These events parallel those observed during the reparative 
response in other tissues, such as the kidney, lung, or blood 
vessels. Therefore, HSC may be regarded to as paradigmatic 
for other myofibroblast-like cells, such as kidney glomerular 
mesangial cells or vascular smooth muscle cells, involved in 
the repair process in other tissues. 
The interaction of HSC with the ECM are mediated, at 
least in part, by integrins, a family of heterodimeric trans- 
membrane adhesion receptors constituted of non-covalently 
associated a- and [3-subunits [21]. We have recently charac- 
terized the main integrin receptors mediating HSC adhesion 
to collagens, fibronectin, and laminin [22]. In addition to their 
role as adhesion receptors, integrins function as signaling re- 
ceptors, and have been shown to regulate cytoskeleton reor- 
ganization, protein kinase activation, and gene expression 
[23,24]. In the present study we provide evidence that inter- 
action between [31-containing integrin receptors and ECM 
components stimulate MCP-I  expression in HSC. These 
data indicate a novel mechanism for MCP-I  secretion, poten- 
tially relevan! for the pathophysiology of liver diseases and 
inflammatory states in general. 
2. Material and methods 
2.1. Materials" and matrix preparation 
Types I and IV collagen were generously provided by Dr. D. 
Schuppan (Free University of Berlin, Germany). Fibronectin and pol- 
ylisine hydrobromide (MW 70 000-150 00) were purchased from Sig- 
ma Chemical Co. (St. Louis, MO). Rabbit anti-baboon MCP-1 anti- 
serum was kindly provided by Dr. A.J. Valente (University of Texas 
Health Science Center at San Antonio, TX). This antiserum cross- 
reacts 100% with human MCP-I. Monoctonal antibodies raised 
against he human 131-integrin (AIIB2) were a kind gift of Dr. C.H. 
Damski (University of California, San Francisco, CA). The ECM 
proteins were dissolved in calcium- and magnesium-free PBS to the 
concentration of 20 gg/ml type I collagen, 10 gg/ml type IV collagen, 
20 gg]ml fibronectin. For coating with AIIB2, the hybridoma super- 
natant was diluted 1:1 with 0.1 M carbonate buffer, pH 9.4. Coating 
of plastic dishes was carried out by overnight incubation at 4°C. The 
dishes were then incubated for 2 h at 37°C with 1% (w/v) BSA dena- 
tured at 70°C tot 15 min, to block the non-specific binding sites on 
plastic, and washed with sterile PBS before cell plating. As control, 
dishes were directly blocked with denatured BSA. For poly-k-lysine 
coating, a 0.1 mg/ml solution was applied for 5 rain, and the dishes 
were then washed once with sterile PBS. 
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2.2. Cell culture 
Human liver HSC were isolated from liver tissue unsuitable for 
transplantation by collagenase/pronase digestion and centrifugation 
on stractan gradients. Procedures used for cell isolation and character- 
ization have been extensively described elsewhere [19,25]. Cells were 
cultured in Iscove's medium supplemented with 17% FCS. 
2.3. Northern blot analysis 
HSC were cultured on plastic dishes in complete medium until 
confluent. The cells were then washed twice with PBS and incubated 
in serum-free, insulin-free (SFIF) medium for 24 h. The medium was 
aspirated and the cells were trypsinized, centrifuged, and resuspended 
in fresh SFIF medium at a concentration of approximately 250 000 
cells/ml. Eight milliliters of the cell suspension were then seeded onto 
100-mm Petri dishes precoated as indicated above, and the cells were 
incubated for the indicated time points. The cells were then scraped in 
their culture medium, centrifuged, and total RNA was isolated as 
described by Chomczynski and Sacchi [26]. Northern blot analysis 
was carried out as previously described [27]. The filters were hybrid- 
ized with a 32p-labeled full-length baboon MCP-1 probe at 42°C, 
washed, and autoradiographed. After removal of the MCP-I probe, 
the same filters were hybridized with a 32p-labeled control probe en- 
coding for the ribosomal protein 36B4 [28]. 
2.4. MCP-1 Western blot 
HSC grown to confluence in complete medium were pre-incubated 
in SFIF medium for 24 h, trypsinized, and resuspended in SFIF 
medium at a concentration of approximately 100000 cells/ml. Identi- 
cal aliquots of cell suspension (750/.tl) were then plated onto 12-well 
plastic dishes precoated with e appropriate ECM component as 
indicated above. After 24 h the conditioned medium was collected, 
briefly spun at 4°C to remove cells, and stored at -80°C until ana- 
lyzed. Conditioned medium (50-100 p.1) was dried and resuspended in 
15 ~1 of Laemmli sample buffer [29]. Western blot analysis was carried 
out as described in detail elsewhere [30]. Briefly, samples were sepa- 
rated by 15% SDS-PAGE analysis and electroblotted on a PVDF 
membrane. The membrane was blocked with 3% BSA in PBS con- 
taining 0.1% Tween-20, then sequentially incubated with anti-baboon 
MCP-I antibodies (1:500 in blocking buffer) and with horseradish 
peroxidase-conjugated anti-rabbit antibodies (1:5000). After extensive 
washing, the signal was detected by chemiluminescence (Amersham, 
Little Chalfont, UK) using the manufacturer's protocol. 
2.5. MCP-1 ELISA 
Cell culture supernatants were obtained and stored as indicated for 
Western blot analysis. MCP-1 concentration was determined using a 
commercial ELISA kit specific for human MCP-1 (R&D Systems, 
Minneapolis, MN). Samples were diluted 40-fold to obtain values 
fitting in the standard curve. 
2.6. Chemotactic assay 
Human blood mononuclear cells were prepared from peripheral 
blood collected in ACD anticoagulant from healthy volunteers, using 
a metrizoate/polysaccaride solution (Lymphoprep, Nycomed Pharma 
AS, Oslo, Norway) according to the manufacturer's protocol. The 
mononuclear cells were washed twice with Ca 2+- and Mg2+-free 
HBSS, counted, and finally resuspendend in Iscove's medium contain- 
ing 0.5% BSA at a concentration of 3 × 106 cells/ml. The chemotaxis 
assay was carried out using polyvinylpirrolidone-free polycarbonate 5 
~tm filters and modified Boyden chambers, as described by Valente et 
al. [3]. HSC-conditioned medium was serially diluted, pre-incubated 
with neutralizing anti-MCP-1 antibodies r non-immune rabbit serum 
for 1 h at 37°C, and placed below the filters. The cell preparation (200 
I11) was placed above the filters and the chambers were incubated at 
37°C for 90 min. After staining with Giemsa, cells migrating to the 
underside of the filters were quantitated as the mean number of cells 
in 10 high-power fields. 
2. 7. Reproducibility and data analys& 
All the autoradiograms and autoluminograms shown are represen- 
tative of at least three independent experiments with comparable re- 
suits. Quantitative data were obtained by densitometry scan of the 
films. Statistical analysis was performed by Student's t test for paired 
data. P < 0.05 was considered significant. 
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Fig. 1. Adhesion on ECM up-regulates MCP-1 gene expression in 
HSC. Serum-starved human HSC were trypsinized and plated on 
dishes coated with BSA (lane 1, non-adhesion), on types I or IV 
collagen, or on fibronectin (lanes 24)  for 4 h. Cells plated on BSA 
were also incubated in the presence of 25 U/ml IL-I~ (lane 5). At 
the end of incubation, total RNA was prepared and Northern blot 
analysis was performed as described in Section 2. 
3. Results and discussion 
We first investigated if adhesion of HSC to different ECM 
proteins could affect MCP-1  gene expression. Serum-starved 
cells were trypsinized and plated on dishes coated with BSA, 
types I or IV collagen, or fibronectin. Plating on BSA resulted 
in a complete lack of attachment, whereas all the cells adhered 
to collagens or fibronectin. MCP-1 mRNA was expressed at 
low levels in serum-starved, non-adherent  HSC, whereas it 
was markedly up-regulated in cells adhering to collagen I, 
collagen IV, or f ibronectin for 4 h (Fig. 1). The average in- 
crease in MCP-1 mRNA levels was 3.3, 3.8, and 2.6-fold, 
comparing types I and IV collagen and fibronectin, respec- 
tively, with BSA (n = 3). Up-regulation of the message for 
MCP-1 was evident as early as 1 h after plating on type I 
collagen and peaked at 4 h (data not shown). To rule out the 
possibility that non-adherent  HSC could be non-specifically 
altered in their ability to express MCP-1, cells plated on 
BSA were incubated with IL-1, a potent inducer of MCP- I  
expression (Fig. 1, lane 5). Incubation with this cytokine re- 
sulted in marked up-regulation of MCP-1 mRNA abundance, 
indicating that non-adherent  cells are capable of responding 
to cytokines in a similar fashion as adherent cells. To deter- 
mine if plating on different ECM proteins results in differ- 
ences in the amount  of protein secreted in the culture medium, 
an identical number  of HSC was plated on BSA, types I or IV 
collagen, or fibronectin, and kept in culture for 24 h. Al iquots 
of the condit ioned medium were then assayed for MCP-1 
using Western blot analysis. This technique is capable of de- 
tecting as little as 1 ng of recombinant human MCP- I  (Fig. 
2A). MCP-1 in the condit ioned media appeared as two bands 
of apparent MW around 10-14 kDa (Fig. 2B, Fig. 3). When 
F. Marra et al./FEBS Letters 414 (1997) 221 225 223 
A B 
rhMCP-1 (ng) 
kDa 1 10 
7 - 
kDa 
19-  
~ o  ~ o ~  
7-  
1 2 3 4 5 
1 2 
Fig. 2. Increased secretion of MCP-I by HSC plated on ECM or 
on anti-131-integrin a tibodies. A: Different amounts of recombinant 
human MCP-1 were separated by 15% SDS-PAGE and analyzed by 
Western blotting with anti-MCP-1 antibodies as described in Section 
2. B: Serum-starved human HSC were trypsinized and an identical 
number of cells was plated on dishes coated with BSA (lane 1, non- 
adhesion), on types 1 or IV collagen (lanes 2 and 3), on fibronectin 
(lane 4) or on dishes coated with the anti-131-integrin antibody 
AIIB2 (lane 5) for 24 h. Aliquots of cell-free conditioned medium 
were analyzed by Western blot analysis for MCP-1. The migration 
of the molecular weight markers is shown on the left. 
HSC were plated on collagens or fibronectin, a marked in- 
crease in the amount of MCP-1 secreted by HSC was ob- 
served in comparison to non-adherent cells (Fig. 2B, lanes 
24) .  Average increase in MCP-I  secretion, as evaluated by 
densitometry scan of the autoluminograms, was approxi- 
mately 3-fold for all ECM components tested (n = 3). 
Types ! and IV collagen and fibronectin interact with 131- 
containing integrin receptors on the cell surface [21]. Cultured 
HSC have been shown to express cd131 and (,2131, which are 
ligands for types 1 and IV collagen, and c,v[31, which interacts 
with fibronectin [22,31]. To establish if the effect of ECM is 
mediated by interaction with these integrin receptors, we 
plated HSC on dishes coated with the monoclonal antibody 
AIIB2, raised against the human [31-subunit. Engagement of 
[31-containing integrins was associated with HSC adhesion, 
and resulted in up-regulation of MCP-1 secretion (3-fold 
over cells plated on BSA, n=3)  (Fig. 2B, lane 5). When 
non-immune mouse IgG were used, neither HSC adhesion 
nor increased secretion of MCP-1 were observed (data not 
shown). Thus, the effect of ECM proteins such as type l 
collagen on MCP-I expression can be reproduced by interac- 
tion with 131-containing integrin receptors. In order to rule out 
that cell adhesion per se or the resulting shape change could 
be involved in the induction of MCP-1 expression, we ana- 
lyzed MCP-I levels in the conditioned medium of HSC plated 
on poly-L-lysine, which mediates integrin-independent cell ad- 
hesion. The number of adhering cells was similar comparing 
HSC plated on poly-L-lysine with those on type I collagen or 
on anti-[31-integrin antibodies, AIIB2. However, MCP-1 con- 
centration in the conditioned medium was increased only 
when HSC were plated on collagen I or on AIIB2, whereas 
in cells plated on poly-L-lysine the levels of the chemokine 
were comparable to those of or non-adherent cells, i.e. plated 
on BSA (Fig. 3A,B). These data indicate that cell adhesion is 
not sufficient to stimulate MCP-1 gene expression, and that 
interaction with an ECM protein, or engagement of an integ- 
rin receptor are required. Pretreatment of HSC with cytocha- 
lasin D, which disrupts the actin cytoskeleton, blocked the 
increase in MCP-1 secretion induced by collagen (Fig. 3C). 
Thus, an intact cytoskeleton is required to stimulate MCP-I  
secretion in response to integrin activation. 
In order to validate the results of Western blot analysis and 
to obtain quantitative data, we measured the concentration of 
MCP-I in HSC-conditioned medium using a specific ELISA. 
These experiments confirmed the increase in MCP-1 secretion 
when HSC plated on type I collagen or on the antiq31-integrin 
antibodies, AIIB2, were compared to non-adherent cells (Fig. 
4A). Previous studies have indicated that adhesion of mono- 
cytes to the ECM induces the xpression of immediate arly 
genes, including those encoding for several cytokines [32,33]. 
However, in that system, adhesion was not sufficient for pro- 
tein translation and secretion without exposure to a second 
activation signal, such as that provided by LPS [23,32]. In this 
report, we provide evidence that interaction of HSC with the 
ECM is an effective stimulus for MCP-I  expression and se- 
cretion in the absence of any additional factors, and that this 
effect is mimicked by ligation of ]31-integrins. To our knowl- 
edge, this is the first report of integrin-dependent stimulation 
of MCP-1 secretion in any cell type, and of a direct relation- 
ship between integrins and chemokines in ECM-producing 
cells. 
Different chemotactic factors for monocytes have been in- 
dividuated, and several of these molecules can be produced by 
cultured cells, including HSC. We therefore investigated 
whether interaction of HSC with ECM was associated with 
an actual increase in the chemotactic activity for mononuclear 
cells, and the contribution of MCP-I to this biologic effect. 
A B 
kDa @~Y" <t°\4"~ o°~"~°~ kDa q~ c°y" @~q" £&4 
19 - 19  - , ~ o  . . . .  
7 - 
1 2 3 
7 - 
1 2 3 
C 
Cytochalasin D 
kDa 
19 
\ \ 
1 2 3 
Fig. 3. Integrin-independent cell adhesion does not increase MCP-1 
secretion. A: Serum-starved human HSC were trypsinized and an 
identical number of cells was plated on dishes coated with BSA, on 
poly-L-lysine, or on type I collagen for 24 h. MCP-I Western blot 
analysis of conditioned medium was carried out as described in Fig. 
2. B: Serum-starved human HSC were trypsinized and an identical 
number of cells was plated on dishes coated with BSA, on dishes 
coated with the anti-l~l-integrin a tibody AIIB2, or on poly-L-lysine 
for 24 h. C: Serum-starved HSC were incubated for 30 min with 
5 jag/ml cytochalasin D or its vehicle (DMSO, final concentration 
0.1%) for 30 min before plating on BSA or collagen I, as indicated, 
for 24 h. MCP-1 Western blot analysis of conditioned medium was 
carried out as described in Fig. 2. The migration of the molecular 
weight markers is shown on the left. 
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Fig. 4. A: Analysis of MCP-I secretion using ELISA. HSC-condi- 
tioned media were obtained from cells plated for 24 h on dishes 
coated with BSA, type I collagen, or with the anti-131-integrin a ti- 
body AIIB2, as described in legend to Fig. 2B. The medium was di- 
luted and assayed using a commercial ELISA kit. Data are mean + 
SEM from 5 independent experiments. *P < 0.05 vs. BSA. B: Integ- 
rin-mediated increase of mononuclear cell chemotactic activity se- 
creted by HSC. HSC conditioned medium was obtained from cells 
plated for 24 h on dishes coated with BSA or type I collagen. The 
media were incubated with non-immune rabbit serum (black col- 
umns or hatched columns for BSA and collagen, respectively) or 
with neutralizing anti-MCP-1 serum (gray columns or white col- 
umns for BSA and collagen, respectively). The chemotactic assay 
was carried out as described in Section 2, using different dilutions 
of the conditioned medium. Data are mean+SEM of three inde- 
pendent experiments. The number of cells migrating with non-condi- 
tioned medium was subtracted from each sample. *P < 0.05 vs. type 
I collagen. 
Plating on type I collagen significantly increased the chemo- 
tactic activity of HSC conditioned medium in comparison to 
cells plated on BSA (Fig. 4B) or poly-L-lysine (data not 
shown). However, when the conditioned medium was pre-in- 
cubated with neutralizing anti-MCP-1 antibodies, the chemo- 
tactic activity was identical, regardless of where the cells were 
plated (Fig. 4B). These data indicate that MCP-1 accounts for 
the great majority of the effect of ECM, while the contribu- 
tion of other chemotactic factors is negligible. 
Upon injury, the liver undergoes a tightly regulated se- 
quence of events aimed at the restoration of the integrity of 
the damaged tissue, similar to what is observed during the 
'wound healing' process in other tissues, such as the kidney 
or the skin. These events include an inflammatory response, in 
which leukocytes are recruited, and a proliferative phase, in 
which myofibroblasts, endothelial cells and other cell types 
migrate into the wound, begin to proliferate, and secrete 
ECM. The HSC, as well as myofibroblasts in other organs, 
participate in both phases of the reaction, through prolifera- 
tion and secretion of ECM components, and via secretion of 
chemotactic factors. Data from the present study identify a 
novel level of interaction in this process. In the normal liver, 
HSC are located in a space almost devoid of ECM, except for 
occasional collagen fibers and a thin, amorphous matrix [34]. 
Upon liver damage, expression of collagen types I, III, IV, 
and VI, fibronectin and other ECM components is dramati- 
cally increased, and the ECM surrounding HSC becomes 
thick and fibrillar [34-37]. According to the data from this 
study, ECM production in the reparative phase could partic- 
ipate in the maintenance of the inflammatory infiltrate by 
inducing secretion of MCP-1 by HSC. This interaction is 
likely to be relevant also in other tissues where this sequence 
of reparative vents takes place, such as during atherosclero- 
sis, or during glomerular injury in the kidney. 
In summary, this study shows that interaction between in- 
tegrin receptors and the ECM represents an effective stimulus 
for MCP-1 gene expression and secretion in HSC. These find- 
ings indicate a novel mechanism of regulation for MCP-1, 
possibly relevant in the hepatic wound healing response and 
in other conditions where ECM alterations occur. 
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